FITC anti-mouse/human CD45R/B220 Antibody

Pricing & Availability
Clone
RA3-6B2 (See other available formats)
Regulatory Status
RUO
Other Names
B220
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
RA3-6B2_FITC
C57BL/6 mouse splenocytes stained with RA3-6B2 FITC
  • RA3-6B2_FITC
    C57BL/6 mouse splenocytes stained with RA3-6B2 FITC
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
103205 50 µg $30
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103206 500 µg $105
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45R, also known as B220, is an isoform of CD45. It is a member of the protein tyrosine phosphatase (PTP) family with a molecular weight of approximately 180-240 kD. CD45R is expressed on B cells (at all developmental stages from pro-B cells through mature B cells), activated B cells, and subsets of T and NK cells. CD45R (B220) is also expressed on a subset of abnormal T cells involved in the pathogenesis of systemic autoimmunity in MRL-Faslpr and MRL-Fasgld mice. It plays a critical role in TCR and BCR signaling. The primary ligands for CD45 are galectin-1, CD2, CD3, and CD4. CD45R is commonly used as a pan-B cell marker; however, CD19 may be more appropriate for B cell specificity.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse, Human
Reported Reactivity
Cat
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Abelson murine leukemia virus-induced pre-B tumor cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone RA3-6B2 has been described to react with an epitope on the extracellular domain of the transmembrane CD45 glycoprotein which is dependent upon the expression of exon A and specific carbohydrate residues. Additional reported applications (for the relevant formats) include: immunoprecipitation1, in vitro and in vivo modulation of B cell responses2-4, immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections5,6, and spatial biology (IBEX)14,15.

Application References

(PubMed link indicates BioLegend citation)
  1. Coffman RL. 1982. Immunol. Rev. 69:5. (IP)
  2. George A, et al. 1994. J. Immunol. 152:1014. (Activ)
  3. Asensi V, et al. 1989. Immunology 68:204. (Activ)
  4. Domiati-Saad R, et al. 1993. J. Immunol. 151:5936. (Activ)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Monteith CE, et al. 1996. Can. J. Vet. Res. 60:193. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Chang C L-T, et al. 2007. J. Immunol. 178:6984.
  9. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  10. Lang GL, et al. 2008. Blood 111:2158. PubMed
  11. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  12. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  13. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
  14. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  15. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Katsumura KR, et al. 2018. Proc Natl Acad Sci U S A. 115:E10109. PubMed
  2. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  3. Zhao J, et al. 2021. Emerg Microbes Infect. 10:913. PubMed
  4. Hutter K, et al. 2022. Front Immunol. 13:967914. PubMed
  5. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  6. Lunardi A, et al. 2015. Cancer Discovery. 5:550. PubMed
  7. Zaman R, et al. 2021. Immunity. :. PubMed
  8. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  9. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  10. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  11. Israelow B, et al. 2020. bioRxiv. . PubMed
  12. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  13. Hata E, et al. 2016. Int Immunol. 28: 283 - 292. PubMed
  14. Engel O, et al. 2015. Stroke. 46: 3232 - 3240. PubMed
  15. Kaku H, et al. 2014. J Immunol. 193:5904. PubMed
  16. Stewart I et al. 2018. Immunity. 49(3):477-489 . PubMed
  17. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  18. Kelly L, et al. 2011. J Immunol. 187:3026. PubMed
  19. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  20. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  21. Chen X, et al. 2021. Theranostics. 11:4655. PubMed
  22. Ota T, et al. 2013. J Immunol. 191:3179. PubMed
  23. Xia S, et al. 2014. J Leukoc Biol. 95:733. PubMed
  24. Tan X, et al. 2016. PLoS One. 11: 0160985. PubMed
  25. Bao H, et al. 2020. Mol Med Rep. 4.675. PubMed
  26. Dong L, et al. 2021. Cancer Cell. . PubMed
  27. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  28. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  29. Ma C, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
  30. Zhu X, et al. 2017. Arch Oral Biol. 10.1016/j.archoralbio.2017.03.010. PubMed
  31. Jones M, et al. 2016. PLoS One. 11: 0157271. PubMed
  32. Wang X, et al. 2016. PLoS Pathog. 12: 1005367. PubMed
  33. Ohyagi M, et al. 2021. Nat Commun. 12:7344. PubMed
  34. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  35. Tu X, et al. 2022. Nat Commun. 13:6977. PubMed
  36. Carbonneau C, et al. 2012. Blood. 119:717. PubMed
  37. Luff DH, et al. 2021. Front Immunol. 631271:12. PubMed
  38. Delgado‐Benito V et al. 2018. Molecular cell. 72(4):636-649 . PubMed
  39. Zanotti KJ, et al. 2019. J Immunol. 202:1573. PubMed
  40. Mariani SA, et al. 2019. Immunity. 50:1439. PubMed
  41. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  42. Huang L, et al. 2017. PLoS Biol.. 10.1371/journal.pbio.2001750. PubMed
  43. Dai B, et al. 2022. Theranostics. 12:7603. PubMed
  44. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  45. Fujikura D, et al. 2013. PLoS One. 8:e55321. PubMed
  46. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  47. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  48. Nakata T, et al. 2020. Proc Natl Acad Sci U S A. 117:28930. PubMed
  49. Yang K, et al. 2022. J Clin Invest. 132:. PubMed
  50. Jing L, et al. 2022. Front Immunol. 13:864995. PubMed
  51. Wang Z, et al. 2021. J Virol. 95:e0141421. PubMed
  52. Zhang X, et al. 2021. Front Immunol. 12:680068. PubMed
  53. Ma Y, et al. 2015. J Immunol. 195: 3769 - 3780. PubMed
  54. Wong R, et al. 2020. Immunity. 53(5):1078-1094.e7. PubMed
  55. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  56. Wang GZ, et al. 2019. Nat Commun. 10:1125. PubMed
  57. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  58. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  59. Yang L, et al. 2021. Cell Death Differ. 28:2616. PubMed
  60. Nabar NR, et al. 2022. Autophagy. 18:204. PubMed
  61. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  62. Köchl R, et al. 2020. Elife. 9:00. PubMed
  63. Pang D, et al. 2015. Clin Transl Immunology. 4: e41. PubMed
  64. Greenwald AC, et al. 2019. J Exp Med. 216:215. PubMed
  65. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  66. Paul S, et al. 2018. Appl Microbiol Biotechnol. 102:8895. PubMed
  67. Marinescu CI, et al. 2021. Stem Cell Res Ther. 12:319. PubMed
  68. Zhu Y, et al. 2022. Clin Transl Med. 12:e887. PubMed
  69. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  70. Hrdinka M, et al. 2016. PLoS One. 11: 0162863. PubMed
  71. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  72. DeVito NC, et al. 2021. Cell Reports. 35(5):109071. PubMed
  73. Noah AC, et al. 2020. J Appl Physiol (1985). 473:128. PubMed
  74. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  75. Hutter K, et al. 2020. FEBS J. . PubMed
  76. Siamishi I, et al. 2020. Cell Reports. 31(11):107756. PubMed
  77. St Clair JB, et al. 2017. PLoS One. 12:e0170556. PubMed
  78. Roy K, et al. 2019. Immunity. 50:616. PubMed
  79. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  80. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  81. Chen X, et al. 2021. Cell Rep. 37:109991. PubMed
  82. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  83. Zhang YN, et al. 2020. EBioMedicine. 56:102819. PubMed
  84. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  85. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  86. Li H, et al. 2020. Nature. 584:274. PubMed
  87. Gu X, et al. 2022. Vaccines (Basel). 10:. PubMed
  88. Ku C, et al. 2015. Genes Dev. 29: 1930-1941. PubMed
  89. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  90. Jamali A, et al. 2020. Cell Reports. 32(9):108099. PubMed
  91. Wittner J, et al. 2022. Mucosal Immunol. 15:668. PubMed
  92. Kang X, et al. 2022. J Immunol Res. 2022:8118577. PubMed
  93. Kondo M, et al. 2016. J Immunol. 196: 563 - 572. PubMed
  94. Hayashi K, et al. 2015. Int Immunol. 27: 435-445. PubMed
  95. Morrison V, et al. 2015. J Immunol. 195: 105 - 115. PubMed
  96. Liu R, et al. 2018. Front Immunol. 9:592. PubMed
  97. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  98. Morelli AE, et al. 2020. Cell Rep. 30:3448. PubMed
  99. Zhang W, et al. 2020. Nat Commun. 11:1187. PubMed
  100. Liu J, et al. 2021. Immun Inflamm Dis. 9:299. PubMed
  101. Liu R, et al. 2021. Mol Cell Biol. 41:e0025121. PubMed
  102. Chen C, et al. 2021. J Virol. 95:e0082921. PubMed
  103. Chen RJ, et al. 2022. iScience. 25:105595. PubMed
  104. Georgoudaki A, et al. 2016. Cell Rep. 15: 2000-2011. PubMed
  105. Baomei Wang et al. 2019. Cell reports. 26(6):1614-1626 . PubMed
  106. Weng TY, et al. 2018. Sci Rep. 8:8216. PubMed
  107. Zhang C, et al. 2021. J Virol. 95:e0079021. PubMed
  108. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  109. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
  110. Hsieh Y, et al. 2014. Infect Immun . 82:2087. PubMed
  111. Schuler F, et al. 2017. Nat Commun. . 10.1038/s41467-017-01850-4. PubMed
  112. Laban H, et al. 2018. J Cell Biol. 217:1503. PubMed
  113. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  114. Raju S, et al. 2020. Cell Reports. 29(9):2556-2564.e3.. PubMed
  115. Sanchez HN, et al. 2020. Nat Commun. 0.5. PubMed
  116. Nguyen HTT, et al. 2021. PLoS Pathog. 17:e1010026. PubMed
  117. Soria-Castro R, et al. 2020. Sci Rep. 10:17802. PubMed
  118. Al-Barwani F, et al. 2014. PLoS One. 9:104523. PubMed
  119. Younes AI, et al. 2021. Transl Oncol. 14:100983. PubMed
  120. Kobia FM, et al. 2020. PLoS Biol. 18:e3000850. PubMed
  121. Ghezraoui H, et al. 2018. Nature. 560:122. PubMed
  122. Tian D, et al. 2019. Nat Commun. 10:4246. PubMed
  123. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  124. Zheng Y, et al. 2022. J Immunol. 208:501. PubMed
  125. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  126. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  127. Velazquez VM, et al. 2017. Mol Ther Methods Clin Dev. 0.277083333. PubMed
  128. Ota T, et al. 2011. J Exp Med. 208:617. PubMed
  129. Tsyklauri O, et al. 2021. EMBO Rep. 22:e50785. PubMed
  130. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  131. Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed
  132. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  133. Takahashi T, et al. 2017. J Exp Med. 10.1084/jem.20160247. PubMed
  134. Li K, et al. 2020. Nat Commun. 4.844444444. PubMed
  135. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  136. Nakamura K, et al. 2018. Cancer Cell. 33:634. PubMed
  137. Pan J, et al. 2022. Front Immunol. 13:812924. PubMed
  138. Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
  139. Iwanami N, et al. 2020. iScience. 23:101260. PubMed
  140. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  141. Ioanna E Galani et al. 2017. Immunity. 46(5):875-890 . PubMed
  142. Jing Y, et al. 2019. J Allergy Clin Immunol. 144:1377. PubMed
  143. Awida Z, et al. 2021. Int J Mol Sci. 23:. PubMed
  144. Tham SM, et al. 2021. Biomedicines. 9:. PubMed
  145. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
RRID
AB_312990 (BioLegend Cat. No. 103205)
AB_312991 (BioLegend Cat. No. 103206)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

B cells, T cell subset, NK cell subset

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4
Cell Type
B cells, NK cells, T cells
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID 5788 View all products for this Gene ID
UniProt
View information about CD45R on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD45R/B220 Reagents Request Custom Conjugation
Description Clone Applications
Alexa Fluor® 594 anti-mouse/human CD45R/B220 RA3-6B2 IHC-F,FC,3D IHC
APC anti-mouse/human CD45R/B220 RA3-6B2 FC
Biotin anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F
FITC anti-mouse/human CD45R/B220 RA3-6B2 FC
PE anti-mouse/human CD45R/B220 RA3-6B2 FC
PE/Cyanine5 anti-mouse/human CD45R/B220 RA3-6B2 FC
Purified anti-mouse/human CD45R/B220 RA3-6B2 FC,CyTOF®,IHC-F,IHC-P,IP,Activ
PE/Cyanine7 anti-mouse/human CD45R/B220 RA3-6B2 FC
APC/Cyanine7 anti-mouse/human CD45R/B220 RA3-6B2 FC
Alexa Fluor® 488 anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F,3D IHC
Alexa Fluor® 647 anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F,3D IHC,SB
Pacific Blue™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Alexa Fluor® 700 anti-mouse/human CD45R/B220 RA3-6B2 FC
PerCP anti-mouse/human CD45R/B220 RA3-6B2 FC
PerCP/Cyanine5.5 anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 421™ anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F
Brilliant Violet 570™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 650™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 605™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 785™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 510™ anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F,SB
Purified anti-mouse/human CD45R/B220 (Maxpar® Ready) RA3-6B2 FC,CyTOF®
Brilliant Violet 711™ anti-mouse/human CD45R/B220 RA3-6B2 FC
PE/Dazzle™ 594 anti-mouse/human CD45R/B220 RA3-6B2 FC
APC/Fire™ 750 anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 750™ anti-mouse/human CD45R/B220 RA3-6B2 FC
TotalSeq™-A0103 anti-mouse/human CD45R/B220 RA3-6B2 PG
Spark Blue™ 550 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark NIR™ 685 anti-mouse/human CD45R/B220 RA3-6B2 FC
TotalSeq™-B0103 anti-mouse/human CD45R/B220 RA3-6B2 PG
Ultra-LEAF™ Purified anti-mouse/human CD45R/B220 RA3-6B2 FC,CyTOF®,IHC-F,IHC-P,IP,Activ
TotalSeq™-C0103 anti-mouse/human CD45R/B220 RA3-6B2 PG
PE/Fire™ 640 anti-mouse/human CD45R/B220 RA3-6B2 FC
APC/Fire™ 810 anti-mouse/human CD45R/B220 RA3-6B2 FC
PE/Fire™ 700 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark Violet™ 538 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark YG™ 581 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark YG™ 570 anti-mouse/human CD45R/B220 RA3-6B2 IHC-F
PE/Fire™ 810 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark Blue™ 574 anti-mouse/human CD45R/B220 Antibody RA3-6B2 FC
Spark Violet™ 423 anti-mouse/human CD45R/B220 Antibody RA3-6B2 FC
Spark Red™ 718 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark UV™ 387 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark PLUS UV™ 395 anti-mouse/human CD45R/B220 RA3-6B2 FC
Go To Top Version: 2    Revision Date: 04/25/2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere

Login/Register
Remember me
Forgot your password? Reset Password
Request an Account